Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest,but not Premanifest,Huntington’s Disease
Restricted accessResearch articleFirst published online 2016
Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest,but not Premanifest,Huntington’s Disease
Background: Visuospatial deficits have been described in Huntington’s disease (HD); however, the extent of these deficits remains unclear. The Benton Judgment of Line Orientation (JoLO) Test, commonly used to assess visuospatial ability, requires minimal motor involvement. It has demonstrated sensitivity to visuospatial deficits in Parkinson’s disease; however, few studies have examined performance on this test in HD.
Objective: The objective of the current study was to assess visuospatial ability in premanifest and manifest HD using the JoLO.
Methods: A global cognitive measure, the Mattis Dementia Rating Scale (DRS), was used to stratify manifest HD patients as mild (DRS ≥129) vs. moderate-severe (DRS ≤128). Fifty mild, 42 moderate-severe, and 30 premanifest HD subjects, as well as 35 matched controls, were administered the JoLO. HD Burden of Pathology (BOP) scores were used as a measure of disease severity.
Results: Results revealed that the total manifest HD sample (p < 0.001), in addition to the mild (p = 0.028), and moderate-severe (p < 0.001), but not premanifest, HD subjects scored significantly lower on the JoLO compared to normal controls.
Conclusions: Our results suggest that the JoLO is useful for detecting visuospatial deficits across various stages of manifest HD. However, any visuospatial impairment that might be present during the premanifest stage of HD was not detected using the JoLO in the present sample.
SalmonPD, HamiltonJM, PeavyGM. Neuropsychological deficits in Huntington’s disease: Implications for striatal function in cognition. In: BollerF, CappaS, editors. Handbook of Neuropsychology, 2nd ed. Amsterdam, Elsevier. 2001.
2.
PeavyGM, JacobsonMW, GoldsteinJL, HamiltonJM, KaneA, GamstAC, et al. Cognitive and functional decline in Huntington’s disease: Dementia criteria revisited. Mov Disord. 2001;25:1163–9.
3.
BrandtJ, ShpritzB, MunroCA, MarshL, RosenblattA. Differential impairment of spatial location memory in Huntington’s disease. J Neurol Neurosurg Psychiatry. 2001;76:1516–9.
4.
Duncan-DavisJ, FiloteoJV, KesnerRP, RobertsJW. Recognition memory for hand positions and spatial locations in patients with Huntington’s disease: Differential visuospatial memory impairment?Cortex. 2003;39:239–53.
5.
LangeKW, SahakianBJ, QuinnNP, MarsdenCD, RobbinsTW. Comparison of executive and visuospatial memory function in Huntington’s disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry. 1995;58:598–606.
6.
LawrenceAD, WatkinsLHA, SahakianBJ, HodgesSR, RobbinsTW. Visual object and visuospatial cognition in Huntington’s disease: Implications for information processing in corticostriatal circuits. Brain. 2000;123:1349–64.
7.
PirogovskyE, NicollDR, ChallenerDM, BreenE, GluhmS, Corey-BloomJ, et al. The visual spatial learning test: Differential impairment during the premanifest and manifest stages of Huntington’s disease. J Neuropsychol. 2015;9:77–86.
8.
LineweaverTT, SalmonDP, BondiMW, Corey-BloomJ. Differential effects of Alzheimer’s disease and Huntington’s disease on the performance of mental rotation. J Int Neuropsychol Soc. 2005;11:30–9.
9.
LemiereJ, DecruyenaereM, Evers-KieboomsG, VandenbusscheE, DomR. Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation–a longitudinal follow-up study. J Neurol. 2004;251:935–42.
10.
BentonAL, SivanAB, HamsherKdeS, VarneyNR, SpreenO. Contributions to neuropsychological assessment: Judgment of line orientation. New York, Oxford University Press. 1994;53–9.
11.
VanderploegR, LaLoneLV, GrebloP, SchinkaJ. Odd-even short forms of the judgment of line orientation test. Appl Neuropsychol. 1997;4:244–6.
12.
MontseA, PereV, CarmeJ, FrancescV, EduardoT. Visuospatial deficits in Parkinson’s disease assessed by judgment of line orientation test: Error analyses and practice effects. J Clin Exp Neuropsychol. 2001;23:592–8.
13.
SoliveriP, MonzaD, PiacentiniS, ParidiD, NespoloC, GelleraC, et al. Cognitive and psychiatric characterization of patients with Huntington’s disease and their at-risk relatives. Neurol Sci. 2002;23:S105–6.
QuallsCE, BliwiseNG, StringerAY. Short forms of the Benton Judgment of Line Orientation Test: Development and psychometric properties. Arch Clin Neuropsychol. 2000;15:159–63.
16.
PaulsenJS, ButtersN, SadekJR, JohnsonSA, SalmonDP, SwerdlowNR, et al. Distinct cognitive profiles of cortical and subcortical dementia in advanced illness. Neurology. 1995;45:951–6.
17.
Huntington Study Group. Unified Huntington’s Disease Rating Scale: Reliability and consistency. Mov Disord. 1996;11:136–42.
18.
PenneyJBJr, VonsattelJ-P, MacDonaldME, GusellaJF, MyersRH. CAG repeat number governs the development rate of pathology in Huntington’s disease. Ann Neurol. 1997;41:689–92.
WoodardJL, BenedictRH, SalthouseTA, TothJP, ZgaljardicDJ, HancockHE. Normative data for equivalent, parallel forms of the judgment of line orientation test. J Clin Exp Neuropsychol. 1998;20:457–62.
21.
ZappacostaB, MonzaD, MeoniC, AustoniL, SoliveriP, GelleraC, et al. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington’s disease. Arch Neurol. 1996;53:493–7.
22.
LemiereJ, DecruyenaereM, Evers-KieboomsG, VandenbusscheE, DomR. Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation–a longitudinal follow-up study. J Neurol. 2004;251:935–42.
23.
GirottiF, MaranoR, SoliveriP, GeminianiG, SciglianoG. Relationship between motor and cognitive disorders in Huntington’s disease. J Neurol. 1998;235:454–7.
24.
BlackmoreL, SimpsonSA, CrawfordJR. Cognitive performance in UK sample of presymptomatic people carrying the gene for Huntington’s disease. J Med Genet. 1995;32:358–62.
25.
DumasEM, van den BogaardSJ, MiddelkoopHA, RoosRA. A review of cognition in Huntington’s disease. Front Biosci. 2013;1:1–18.
